MYRIAD GENETICS, INC.

Sector consensus Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-17 pm EST			5-day change	1st Jan Change
12.39 ^USD	-1.04%		-16.45%	-9.63%

Jan. 15	Myriad Genetics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 03:45 PM
Jan. 15	Myriad Genetics Expects Higher Q4 Revenue, Provides 2025 Guidance	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Target Price Revision	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Average Target P.	Ecart obj. / dr	Nbr of analysts
	MYRIAD GENETICS, INC.						21.44	+73.04%	15
	BIOMÉRIEUX						120.60	+9.04%	15
	SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.						85.65	+40.09%	9
	LANTHEUS HOLDINGS, INC.						134.69	+47.25%	13
	DIASORIN S.P.A.						106.27	+4.29%	13
	GUARDANT HEALTH, INC.						44.11	+20.31%	19
	AUTOBIO DIAGNOSTICS CO., LTD.						58.57	+46.00%	5
	VITROLIFE AB						272.00	+30.77%	4
	10X GENOMICS, INC.						20.08	+33.14%	13
	SANSURE BIOTECH INC.						24.45	+23.17%	2
	GUANGZHOU WONDFO BIOTECH CO.,LTD						33.26	+50.50%	2
	SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD.		-				21.90	+46.00%	2
	VCANBIO CELL & GENE ENGINEERING CORP., LTD		-		-	-	-	-	-
	AMOY DIAGNOSTICS CO., LTD.						31.13	+44.66%	5
	MACCURA BIOTECHNOLOGY CO.LTD					-	13.79	+9.71%	1
	BEIJING STRONG BIOTECHNOLOGIES,INC.					-	23.15	+79.60%	1
	SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.						22.31	+57.19%	2
	Average						64.59	+38.42%	8
	Weighted average by Cap.						93.11	+28.52%	11

Diagnostic & Testing Substances